Bart concentrates on mergers, acquisitions, and healthcare regulatory compliance. His practice includes advising healthcare providers as well as equity sponsors and lenders to the healthcare industry. In connection with representing healthcare providers, he works with hospitals, ambulatory surgery centers, diagnostic laboratories, large physician group practices, end-stage renal disease facilities, and home health and DME companies on various regulatory and transactional matters.

He has represented lenders, borrowers and equity sponsors in various healthcare-related financing and acquisition transactions, including asset-based lending, mezzanine and senior credit facilities, and leveraged debt finance. He has assisted in the re-syndication and start-up of numerous ambulatory surgery centers and hospital-physician joint ventures. He regularly lectures and writes on transactional and regulatory issues affecting a wide range of healthcare businesses.

While earning his law degree from the University of Notre Dame, Bart was named a White Scholar of the Thomas J. White Center on Law and Government. As an undergraduate, he was named a Morehead Scholar at the University of North Carolina at Chapel Hill.